arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

ARROWHEAD PHARMACEUTICALS, INC.

ARWR
$87.66 ▲ +1.86 (+2.17%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
83 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
56
Health
Fair
Neutral
auto_awesome

Analytical Summary

ARROWHEAD PHARMACEUTICALS, INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $12.5B
Dividend Yield
Revenue Growth -86.4%
Op. Margin -191.6%
ROIC -23.0%
FCF / Share $0.57
Trailing P/E
Price / Book 20.1x
FCF Yield 0.7%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

83-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$73.74M
↓ -86.4%
Net Income Profit after all expenses
$-132.73M
↓ -530.8%
Operating Margin Operating profit as % of sales
-191.6%
↓ -1339.5% 61th
FCF / Share Free cash flow per share
$0.57
↑ +595.2%

Health Breakdown

Profitability
57
Returns
43
Financial Health
100
Cash Quality
0

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 23 years · 83 quarters